Literature DB >> 19144890

Simple prepregnant prediction rule for recurrent early-onset hypertensive disease in pregnancy.

Simone J S Sep1, Luc J M Smits, Martin H Prins, Marc E A Spaanderman, Louis L H Peeters.   

Abstract

OBJECTIVE: We aimed to develop a simple clinically useful prediction rule for early-onset recurrent preeclampsia and/or HELLP syndrome.
METHODS: Women with previous early-onset preeclampsia and/or HELLP, enrolled between 1996 and 2007, and a subsequent ongoing pregnancy were included. Prepregnant cardiovascular, metabolic, renal, and clotting parameters were evaluated as potential predictors for recurrent disease by logistic regression analysis.
RESULTS: Early-onset preeclampsia and/or HELLP recurred in 16 (9%) of 186 next pregnancies. The prediction model included high-density lipoprotein (mmol/L) and 24-hour urinary total protein excretion (mg/mmol creatinine). The receiver operating characteristic area was 0.77 (95% confidence interval: 0.68-0.87). Predictive sensitivity and specificity were 94% (69%-99%) and 53% (45%-60%), respectively. Nearly 50% of the women could be classified as having <1% risk of recurrent early-onset disease.
CONCLUSIONS: The prediction rule identified, with clinically relevant predictive capacity, those women at very low risk for recurrent early-onset disease.

Entities:  

Mesh:

Year:  2009        PMID: 19144890     DOI: 10.1177/1933719108324889

Source DB:  PubMed          Journal:  Reprod Sci        ISSN: 1933-7191            Impact factor:   3.060


  4 in total

1.  Early-Pregnancy Circulating Antioxidant Capacity and Hemodynamic Adaptation in Recurrent Placental Syndrome: An Exploratory Study.

Authors:  Carmen A H Severens-Rijvers; Salwan Al-Nasiry; Annemiek Vincken; Guido Haenen; Bjorn Winkens; Chahinda Ghossein-Doha; Marc A E Spaanderman; Louis L H Peeters
Journal:  Gynecol Obstet Invest       Date:  2019-07-29       Impact factor: 2.031

2.  Circulating Fibronectin and Plasminogen Activator Inhibitor-2 Levels as Possible Predictors of Recurrent Placental Syndrome: An Exploratory Study.

Authors:  Carmen A H Severens-Rijvers; Salwan Al-Nasiry; Chahinda Ghossein-Doha; Sara Marzano; Hugo Ten Cate; Bjorn Winkens; Marc A E Spaanderman; Louis L H Peeters
Journal:  Gynecol Obstet Invest       Date:  2016-09-20       Impact factor: 2.031

3.  Cost-effectiveness of recurrence risk guided care versus care as usual in women who suffered from early-onset preeclampsia including HELLP syndrome in their previous pregnancy (the PreCare study).

Authors:  Denise H J Delahaije; Sander M J van Kuijk; Carmen D Dirksen; Simone J S Sep; Louis L Peeters; Marc E Spaanderman; Hein W Bruinse; Laura D de Wit-Zuurendonk; Joris A M van der Post; Johannes J Duvekot; Jim van Eyck; Mariëlle G van Pampus; Mark A B H M van der Hoeven; Luc J Smits
Journal:  BMC Pregnancy Childbirth       Date:  2010-10-11       Impact factor: 3.007

4.  A multistate competing risks framework for preconception prediction of pregnancy outcomes.

Authors:  Kaitlyn Cook; Neil J Perkins; Enrique Schisterman; Sebastien Haneuse
Journal:  BMC Med Res Methodol       Date:  2022-05-30       Impact factor: 4.612

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.